AB
ABBV
Market ClosedAbbVie Inc.
US
57.00K employees
CEO: Robert A. Michael
Founded: 2013
$243.87
+$0.00(+NaN%)
Market Cap
430.87B
Beta
0.28
52W Range
N/A
Dividend Yield
2.80%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
AbbVie's AI 30-day forecast is trending modestly lower, indicating short-term downside risk. Analyst consensus projects a modest 12-month upside with strong coverage and tightly aligned estimates, reflecting confidence and limited disagreement. This combination signals short-term caution alongside longer-term stability.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for ABBV
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore ABBV
ABBV in the Healthcare
Mega Cap